Literature DB >> 33585126

Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors.

Atif A Hashmi1, Javaria Ali1, Syed Rafay Yaqeen2, Omer Ahmed3, Ishaq Azeem Asghar4, Muhammad Irfan5, Muhammad Ghani Asif6, Muhammad M Edhi7, Shumaila Hashmi8.   

Abstract

Introduction The two broad subcategories of neuroendocrine neoplasms (NENs) are well-differentiated neuroendocrine tumors (WDNETs) and poorly differentiated neuroendocrine carcinomas (PDNECs), based on tumor architecture and cytology. Grade 3 WDNETs are a subset of WDNETs that not only are high grade by mitotic activity or proliferative index but exhibit a well-differentiated histology. In this study, we evaluated the clinicopathological features of primary neuroendocrine tumors of the gastrointestinal (GI)/pancreatobiliary tract with emphasis on high-grade WDNETs, as it is a newly defined entity. Methods We conducted a retrospective observational study, including a total number of 122 cases of primary GI and pancreatobiliary tract NENs. Slides and blocks of all cases were retrieved from the departmental archives. Immunohistochemical stains including Ki67 were applied to selected tissue blocks of all cases. Tumors were then evaluated for their histological differentiation and tumor grade. Results Our results showed that the mean age of patients was 46.8 ± 17.1 years. Majority of the NENs were GI tract origin (86.9%). The most common site of tumor in gastroenteropancreatic tract was the small bowel (31.1%), followed by the stomach (26.2%). Ninety five percent of the tumors were WDNETs, of which the most common grade was G2. The mean Ki67 index was 15.8 ± 23.8. Grade 3 WDNETs were noted to have an older mean age than grades 1 and 2 WDNETs. Ten out of 102 (9.8%) WDNETs of GI tract were grade 3, compared with four out of 14 (28.6%) of pancreatobiliary tract.  Conclusion In this study, we found that high-grade (grade 3) WDNETs were more frequent in pancreatobiliary tract than GI tract. Moreover, high-grade WDNETs were associated with a higher mean age than low-grade (grade 1-2) WDNETs. It is extremely important to recognize this subset (high grade) of WDNETs and to distinguish it from PDNECs, as the latter are known to be associated with a worse overall survival. Despite high mitotic rate/proliferative index, high-grade WDNETs are characterized by organoid architecture and monomorphic cell population.
Copyright © 2021, Hashmi et al.

Entities:  

Keywords:  gastrointestinal tract; high-grade neuroendocrine tumor; neuroendocrine neoplasms; neuroendocrine tumor (net); pancreatobiliary tract; poorly differentiated neuroendocrine carcinoma (pdnec); well-differentiated neuroendocrine tumor (wdnet)

Year:  2021        PMID: 33585126      PMCID: PMC7872883          DOI: 10.7759/cureus.12640

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

1.  Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.

Authors:  Laura H Tang; Brian R Untch; Diane L Reidy; Eileen O'Reilly; Deepti Dhall; Lily Jih; Olca Basturk; Peter J Allen; David S Klimstra
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

2.  Karnofsky memorial lecture. An odyssey in the land of small tumors.

Authors:  C G Moertel
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

Review 3.  Current status of gastrointestinal carcinoids.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Michael D Shapiro
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 4.  The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.

Authors:  David S Klimstra; Irvin R Modlin; Domenico Coppola; Ricardo V Lloyd; Saul Suster
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 5.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

6.  The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.

Authors:  Massimo Milione; Patrick Maisonneuve; Francesca Spada; Alessio Pellegrinelli; Paola Spaggiari; Luca Albarello; Eleonora Pisa; Massimo Barberis; Alessandro Vanoli; Roberto Buzzoni; Sara Pusceddu; Laura Concas; Fausto Sessa; Enrico Solcia; Carlo Capella; Nicola Fazio; Stefano La Rosa
Journal:  Neuroendocrinology       Date:  2016-03-05       Impact factor: 4.914

7.  Incidence and management of malignant digestive endocrine tumours in a well defined French population.

Authors:  C Lepage; A M Bouvier; J M Phelip; C Hatem; C Vernet; J Faivre
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 8.  Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Mauro Cives; Jonathan R Strosberg
Journal:  CA Cancer J Clin       Date:  2018-10-08       Impact factor: 508.702

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  Clinicopathological Spectrum of Primary and Metastatic Neuroendocrine Neoplasms.

Authors:  Atif A Hashmi; Javaria Ali; Kiran Khan; Omer Ahmed; Ata Ur Rehman; Muhammad Irfan; Saroona Haroon; Muhammad Ghani Asif
Journal:  Cureus       Date:  2020-11-29
View more
  3 in total

1.  Ki67 Proliferation Index in Germinal and Non-Germinal Subtypes of Diffuse Large B-Cell Lymphoma.

Authors:  Atif A Hashmi; Syeda N Iftikhar; Gul Nargus; Omer Ahmed; Ishaq Azeem Asghar; Umme Aiman Shirazi; Anoshia Afzal; Muhammad Irfan; Javaria Ali
Journal:  Cureus       Date:  2021-02-04

Review 2.  Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway.

Authors:  Eileen M McGowan; Yiguang Lin; Size Chen
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

3.  Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.

Authors:  Zubaria Rafique; Aafia Qasim; Asma Zafar; Seemal Ali; Akhtar S Chughtai; Aribah Atiq
Journal:  Cureus       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.